Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 2
1987 1
1989 1
1996 1
1998 2
1999 2
2000 2
2004 2
2011 1
2013 1
2014 2
2015 4
2016 4
2017 6
2018 3
2019 1
2020 6
2021 7
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy for laryngeal cancers.
Biau J, Pointreau Y, Blanchard P, Khampan C, Giraud P, Lapeyre M, Maingon P. Biau J, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):206-212. doi: 10.1016/j.canrad.2021.09.004. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953705
We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours …
We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensi …
Patterns of Failure After Definitive Treatment of T4a Larynx Cancer.
Voora RS, Panuganti BA, Flagg M, Nelson T, Kotha NV, Qiao EM, Qian AS, Kumar A, Stewart TF, Rose B, Califano J, Weissbrod PA, Mell LK, Orosco RK. Voora RS, et al. Otolaryngol Head Neck Surg. 2022 Aug;167(2):274-285. doi: 10.1177/01945998211049211. Epub 2021 Oct 5. Otolaryngol Head Neck Surg. 2022. PMID: 34609937
Secondary outcomes of overall mortality, larynx cancer mortality, and noncancer mortality were evaluated in Cox and Fine-Gray models. ...On multivariable regression, surgery demonstrated favorable locoregional recurrence (hazard ratio [HR], 0.49; 95% CI, 0.39-0.62; …
Secondary outcomes of overall mortality, larynx cancer mortality, and noncancer mortality were evaluated in Cox and Fine-Gray …
Transoral and Transcervical Surgical Innovations in the Treatment of Glottic Cancer.
Zeitels SM. Zeitels SM. Otolaryngol Clin North Am. 2015 Aug;48(4):677-85. doi: 10.1016/j.otc.2015.04.012. Otolaryngol Clin North Am. 2015. PMID: 26233792 Review.
Transoral and transcervical surgery to treat glottic cancer has advanced substantially over the past decade. There have been considerable innovations that enhance vocal function for early disease and airway function for advanced disease. The fiber-based angiolytic 532 nm p …
Transoral and transcervical surgery to treat glottic cancer has advanced substantially over the past decade. There have been consider …
Patient Reflections on Decision Making for Laryngeal Cancer Treatment.
Shuman AG, Larkin K, Thomas D, Palmer FL, Fins JJ, Baxi SS, Lee N, Shah JP, Fagerlin A, Patel SG. Shuman AG, et al. Otolaryngol Head Neck Surg. 2017 Feb;156(2):299-304. doi: 10.1177/0194599816683377. Epub 2017 Jan 24. Otolaryngol Head Neck Surg. 2017. PMID: 28116989 Free PMC article.
Setting Single-institution tertiary care cancer center. Subjects/Methods Adults with laryngeal carcinoma were eligible to participate (N = 57; 46% treated surgically, 54% nonsurgically). ...Results When considering the level of involvement of surgeons, radiation onc …
Setting Single-institution tertiary care cancer center. Subjects/Methods Adults with laryngeal carcinoma were eligible to part …
Chronic opioid use after laryngeal cancer treatment.
Starr N, Oyler DR, Schadler A, Aouad RK. Starr N, et al. Head Neck. 2021 Apr;43(4):1242-1251. doi: 10.1002/hed.26591. Epub 2020 Dec 28. Head Neck. 2021. PMID: 33368718
BACKGROUND: Survivors of head and neck cancer may be at increased risk for chronic opioid use and questions remain about risk factors. METHODS: Retrospective study of patients with laryngeal cancer prescribed opioids utilizing the Truven Health Marketscan database. …
BACKGROUND: Survivors of head and neck cancer may be at increased risk for chronic opioid use and questions remain about risk factors …
The pathology and management of subglottic cancer.
Ferlito A, Rinaldo A. Ferlito A, et al. Eur Arch Otorhinolaryngol. 2000;257(3):168-73. doi: 10.1007/s004050050217. Eur Arch Otorhinolaryngol. 2000. PMID: 10839493 Review.
Because there is still considerable controversy concerning the anatomical boundaries separating the three regions of the larynx, cancer of the subglottis remains difficult to manage. We have reviewed the numerous differences in the anatomical definitions used in the …
Because there is still considerable controversy concerning the anatomical boundaries separating the three regions of the larynx, c …
Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
Burbure N, Handorf E, Ridge JA, Bauman J, Liu JC, Giri A, Galloway TJ. Burbure N, et al. Head Neck. 2021 Oct;43(10):3042-3052. doi: 10.1002/hed.26793. Epub 2021 Jun 24. Head Neck. 2021. PMID: 34165223 Free PMC article.
BACKGROUND: Management of hypopharynx cancer is often extrapolated from larynx cancer. This report analyses treatment patterns and survival limited to hypopharynx cancer using the National Cancer Database (NCDB). ...Treatment modality did not in …
BACKGROUND: Management of hypopharynx cancer is often extrapolated from larynx cancer. This report analyses treatment p …
Treatment, short-term outcomes, and costs associated with larynx cancer care in commercially insured patients.
Day AT, Chang HY, Quon H, Kang H, Kiess AP, Eisele DW, Frick KD, Gourin CG. Day AT, et al. Laryngoscope. 2018 Jan;128(1):91-101. doi: 10.1002/lary.26717. Epub 2017 Jul 7. Laryngoscope. 2018. PMID: 28685830
Initial treatment and 1-year overall costs for chemoradiation were higher than all other treatment categories, after controlling for all other variables including complications and salvage. High-volume care was associated with significantly lower costs of care for s …
Initial treatment and 1-year overall costs for chemoradiation were higher than all other treatment categories, after controlling for all oth …
Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer.
Lee MY, Belfiglio M, Zeng J, Fleming CW, Koyfman S, Joshi NP, Lamarre E, Prendes B, Scharpf J, Lorenz RR, Woody NM, Adelstein DJ, Geiger JL, Chute DJ, Ku JA. Lee MY, et al. Laryngoscope. 2023 May;133(5):1122-1131. doi: 10.1002/lary.30254. Epub 2022 Jun 26. Laryngoscope. 2023. PMID: 35754153
OBJECTIVE: Organ preservation (OP) treatment for advanced laryngeal cancer has increased compared to primary total laryngectomy. Our study compares oncologic and functional outcomes between these approaches. STUDY DESIGN: Retrospective cohort study. SETTING: Single tertiar …
OBJECTIVE: Organ preservation (OP) treatment for advanced laryngeal cancer has increased compared to primary total laryngectomy. Our …
45 results